Literature DB >> 20565409

Sugammadex in patients with myasthenia gravis.

H D De Boer1, J Van Egmond1, J J Driessen1, L H J D Booij1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20565409     DOI： 10.1111/j.1365-2044.2010.06360.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN： 0003-2409            Impact factor:   6.955


× No keyword cloud information.
  9 in total

1.  Sugammadex in the management of myasthenic patients undergoing surgery: beyond expectations.

Authors:  Michele Carron; Alessandro De Cassai; Federico Linassi
Journal:  Ann Transl Med       Date:  2019-12

2.  Anaesthetic considerations in paediatric myasthenia gravis.

Authors:  Oliver William Masters; Oliver N Bagshaw
Journal:  Autoimmune Dis       Date:  2011-09-25

3.  Sugammadex and reversal of neuromuscular block in adult patient with duchenne muscular dystrophy.

Authors:  Ahmed Abdelgawwad Wefki Abdelgawwad Shousha; Maria Sanfilippo; Antonio Sabba; Paolo Pinchera
Journal:  Case Rep Anesthesiol       Date:  2014-03-13

Review 4.  Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature.

Authors:  Hermann Dos Santos Fernandes; Jorge Luiz Saraiva Ximenes; Daniel Ibanhes Nunes; Hazem Adel Ashmawi; Joaquim Edson Vieira
Journal:  BMC Anesthesiol       Date:  2019-08-17       Impact factor: 2.217

5.  Myasthenia gravis and sugammadex: A case report and review of the literature.

Authors:  Sujana Dontukurthy; Carrie Wisler; Vidya Raman; Joseph D Tobias
Journal:  Saudi J Anaesth       Date:  2020-03-05

Review 6.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

7.  The use of sugammadex in a patient with Kennedy's disease under general anesthesia.

Authors:  Risa Takeuchi; Hiroshi Hoshijima; Katsushi Doi; Hiroshi Nagasaka
Journal:  Saudi J Anaesth       Date:  2014-07

8.  Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases.

Authors:  Tomas Vymazal; Martina Krecmerova; Vladimír Bicek; Robert Lischke
Journal:  Ther Clin Risk Manag       Date:  2015-10-15       Impact factor: 2.423

9.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.